Clinical Trial 51627

Raleigh, NC 27607


Summary:

Primary Biliary Cholangitis may be rare, but we are working together

If you are living with Primary Biliary Cholangitis, learn about our study of a novel combination therapy.



To participate, you must:

  • Be at least 18 years old and have diagnosis of PBC
  • Have been taking a stable dose of UDCA for at least the past year, or have not taken any UDCA in the past 3 months
  • Not have other conditions that affect the liver, such as hepatitis B, or C, autoimmune hepatitis (AIH), alcoholic liver disease, nonalcoholic steatohepatitis (NASH), etc.


Qualified Participants May Receive:

Compensation for time and travel


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.